StonvexLoading…
StonvexStonvexStonvexCore line items from HBM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.21B | $2.02B | $1.69B | $1.46B |
Operating Income | $916.50M | $400.30M | $297.10M | $214.31M |
Net Income | $564.30M | $67.80M | $69.50M | $70.38M |
EPS (Diluted) | $1.44 | $0.20 | $0.22 | $0.27 |
Total Assets | $6.22B | $5.49B | $5.31B | $4.33B |
Total Liabilities | $2.99B | $2.84B | $3.11B | $2.75B |
Cash & Equivalents | $568.90M | $541.80M | $249.80M | $225.70M |
Free Cash Flow OCF − CapEx | $240.60M | $319.10M | $195.80M | $178.84M |
Shares Outstanding | Not available | Not available | Not available | Not available |